Is the Drug Development Pathway worth pursuing?

I was recently discussing the FDA’s Drug Development Tool (DDT) qualification program with a colleague. They questioned the utility of the pathway and I’ve heard similar sentiment from others over the past year or two. For people not deeply familiar with the DDT pathway here’s some additional context: The pathway was created in 2016 as part of the 21st Century Cures Act and outlined 3 streams: 1)…